Fatal anaphylaxis, also known as anaphylactic shock or anaphylactic reaction. It is a severe and life-threatening allergic reaction that can occur when an individual is exposed to an allergen to which they are highly sensitive. Anaphylaxis is a medical emergency that requires immediate attention and treatment.
Fatal Anaphylaxis can be triggered by a wide range of allergens. Common allergens include foods (such as peanuts, tree nuts, shellfish, and eggs), insect stings (like bee or wasp stings), medications (especially antibiotics and non-steroidal anti-inflammatory drugs), latex, and certain chemicals.
The symptoms of anaphylaxis can vary but typically include swelling of the face and throat, difficulty in breathing, a drop in blood pressure, rapid and weak pulse, hives or rash, and a sense of impending doom.
When a person with a severe allergy is exposed to their allergen, their immune system reacts excessively to the perceived threat. This immune response involves the release of various chemicals, including histamines, which can lead to a rapid and severe allergic reaction.
Epidemiology
Fatal anaphylaxis is relatively rare, but it can occur in individuals of all ages. The exact incidence varies by region and population. Studies have reported an estimated incidence of 0.001% to 0.005% of the general population per year.
Fatal anaphylaxis can affect individuals of any age, but it appears to be more common in adults and older individuals.
The most common triggers of fatal anaphylaxis include food allergens, insect stings and medications (e.g., antibiotics, non-steroidal anti-inflammatory drugs).
Individuals who experience fatal anaphylaxis have a history of known allergies. Having a previous history of severe allergic reactions or a history of anaphylaxis is a significant risk factor.
Anatomy
Pathophysiology
Fatal anaphylaxis begins when an individual with a heightened sensitivity to a specific allergen is exposed to that allergen.
Anaphylaxis can lead to severe bronchoconstriction because of mediators on the smooth muscles of the respiratory system. This can result in difficulty breathing and respiratory distress.
In individuals with a history of allergy, their immune system has previously been sensitized to the allergen. Upon re-exposure, the allergen interacts with specific IgE antibodies bound to mast cells and basophils, triggering an immediate hypersensitivity reaction.
The interaction between the allergen and IgE antibodies on mast cells and basophils leads to degranulation, causing the release of various inflammatory mediators.
Etiology
In cases of food allergies, cross-contamination of allergenic substances can lead to inadvertent exposure. This can occur in restaurants, food processing facilities, or homes.
Insect stings, especially from bees and wasps, are a common cause of anaphylaxis. Fatal anaphylaxis occurs when an individual with a heightened sensitivity to a specific allergen is exposed to that allergen,
A significant risk factor for fatal anaphylaxis is a history of known allergies and prior allergic reactions. Individuals who have previously experienced severe allergic reactions, including anaphylaxis, are at higher risk of experiencing a fatal reaction upon subsequent exposure to the allergen.
Genetics
Prognostic Factors
The most critical prognostic factor in fatal anaphylaxis is the time it takes to initiate appropriate treatment, particularly the administration of epinephrine. Early administration of epinephrine is associated with better outcomes, while delays in treatment can increase the risk of a fatal outcome.
The severity of the allergic reaction plays a significant role in prognosis. More severe reactions, characterized by widespread symptoms such as difficulty breathing, low blood pressure, and altered consciousness, are associated with a higher risk of a fatal outcome.
Age can be a prognostic factor, with pediatric patients often having better outcomes than adults in cases of fatal anaphylaxis. However, severe reactions can occur at any age.
The presence of underlying health conditions, such as cardiovascular disease or respiratory disorders like asthma, can influence the prognosis of fatal anaphylaxis.
Clinical History
Fatal anaphylaxis can occur in infants and children, but it is relatively rare in this age group. Food allergies are often a significant trigger for anaphylactic reactions in children.
Adolescents and young adults can also experience fatal anaphylaxis, especially if they have known allergies and are exposed to their allergens.
Fatal anaphylaxis can occur in adults of all ages. Adults may have a higher prevalence of medication-related anaphylactic reactions, particularly reactions to antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs).
Physical Examination
Respiratory Assessment: Observe the patient’s breathing rate and effort. Listen for wheezing, stridor (high-pitched breathing sounds), or other abnormal breath sounds.
Cardiovascular Assessment: Measure the patient’s heart rate (pulse) and blood pressure. In fatal anaphylaxis, there is typically tachycardia (rapid heart rate) and hypotension (low blood pressure).
Skin Assessment: Look for hives or a widespread rash, which is a common sign of anaphylaxis.
Neurological Assessment: Evaluate the patient’s level of consciousness, alertness, and orientation. In severe cases, anaphylaxis can lead to altered mental status or loss of consciousness.
Gastrointestinal Assessment: Examine for nausea, vomiting, abdominal pain, or diarrhea, which may be present in some cases of anaphylaxis.
Oral and Oropharyngeal Examination: Examine the oral cavity and oropharynx for any signs of swelling, including the uvula, tonsils, and posterior pharynx.
Age group
Associated comorbidity
Individuals with asthma are at increased risk of severe anaphylaxis. Asthma and anaphylaxis share common features, such as airway inflammation and bronchoconstriction.
When anaphylaxis occurs in individuals with poorly controlled or severe asthma, it can lead to more pronounced respiratory symptoms and a higher risk of respiratory Individuals with cardiovascular conditions, such as coronary artery disease or congestive heart failure, may be at greater risk during anaphylaxis due to the potential for severe drops in blood pressure (hypotension).
Certain autoimmune disorders, such as lupus or rheumatoid arthritis, may affect the immune system and could potentially alter the severity or presentation of anaphylactic reactions.
Individuals with primary immunodeficiency disorders may have impaired immune responses, which can affect their ability to mount a typical allergic response.
Associated activity
Acuity of presentation
Fatal anaphylaxis often has a rapid onset. In many cases, symptoms can develop within minutes of allergen exposure, and the reaction can progress swiftly.
As the allergic reaction worsens, individuals may experience severe respiratory distress. This can include wheezing, stridor (high-pitched breathing sounds), and a sense of suffocation. The airways may become severely narrowed due to bronchoconstriction and swelling.
Differential Diagnoses
Stroke: Stroke can sometimes cause neurological symptoms that overlap with those seen in severe allergic reactions, such as altered mental status, confusion, or weakness on one side of the body. Brain imaging (e.g., CT or MRI) can help diagnose a stroke.
Pulmonary Embolism: A pulmonary embolism, a blood clot in the lung arteries, can lead to sudden shortness of breath and chest pain, which may be mistaken for anaphylaxis.
Seizures: Seizures can present with confusion, altered consciousness, and muscle twitching or rigidity, which might be confused with symptoms of anaphylaxis.
Vasovagal Syncope: Vasovagal syncope due to a sudden drop in blood pressure and heart rate, can resemble anaphylaxis with symptoms like dizziness, nausea, and loss of consciousness.
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Identification of Anaphylaxis: The first step in the treatment paradigm is recognizing the signs and symptoms of anaphylaxis, which can include difficulty breathing, swelling of the face and throat, a drop in blood pressure, hives, nausea, and a sense of impending doom.
Contact Emergency Assistance: As soon as anaphylaxis is suspected, call the local emergency number for immediate medical assistance. Time is of the essence in anaphylaxis management.
Administration of Epinephrine: Epinephrine is the first-line treatment for anaphylaxis and is administered via an epinephrine auto-injector (e.g., EpiPen) into the outer thigh muscle.
Start with Cardiopulmonary Resuscitation (CPR): If the individual loses consciousness and their pulse stops (cardiac arrest).
Avoid Allergen: Identify and confirm specific allergens that trigger anaphylactic reactions in individuals with allergies.
Food Allergy Management: In homes and kitchens, establish safe and unsafe food areas to prevent cross-contact. Ensure that food preparation surfaces and utensils are thoroughly cleaned after use.
Medication Allergies: Inform healthcare providers and pharmacists about known medication allergies to prevent the administration of allergenic medications.
Wear a medical alert bracelet or necklace that specifies medication allergies.
Insect Sting Allergies: For individuals with insect sting allergies, take precautions when outdoors, especially during warm seasons. Wear protective clothing and consider carrying insect repellent.
Administration of Pharmaceutical Agents with Drugs
These agents help maintain blood pressure, antagonize effects of released mediators, and prevent further release of mediators.
Epinephrine: Epinephrine is the first line and most critical medication for anaphylaxis. It acts rapidly to counteract many of the effects of the allergic reaction.
Epinephrine works by constricting blood vessels, which helps raise blood pressure, and by relaxing the muscles in the airways, which improves breathing.
Epinephrine is typically administered via an epinephrine auto-injector into the outer thigh muscle.
Use of Antihistamines
Antihistamines, such as diphenhydramine, can be administered to help relieve symptoms like hives, itching, and runny nose.
Antihistamines block the effects of histamine, a chemical released during an allergic reaction.
Diphenhydramine: Diphenhydramine is an H1-receptor antagonist, which means it blocks the effects of histamine, a chemical released during an allergic reaction. By doing so, it can help alleviate symptoms associated with histamine release, such as itching, hives, and runny nose.
Diphenhydramine is typically administered as an adjunctive therapy in the treatment of anaphylaxis. It can help provide relief from itching and skin reactions caused by histamine release.
Hydroxyzine: Hydroxyzine is an H1-receptor antagonist with similar actions in blocking histamine effects. It also has anxiolytic (anxiety-reducing) properties.
Hydroxyzine may be used similarly to diphenhydramine as an adjunctive therapy in the treatment of anaphylaxis. It can help alleviate symptoms like itching and skin reactions.
Use of Bronchodilators
Bronchodilators like albuterol may be used to relieve bronchoconstriction and improve breathing in individuals with significant respiratory symptoms. They relax the smooth muscles in the airways, making it easier to breathe.
Albuterol: It is a beta-2 adrenergic agonist that works by relaxing the smooth muscles in the airways. It helps open the air passages and improve breathing by relieving bronchoconstriction.
Albuterol may be used as an adjunctive therapy in the treatment of anaphylaxis when there are significant respiratory symptoms, such as wheezing and shortness of breath.
Use of Corticosteroids
Corticosteroids have anti-inflammatory properties that can help prevent delayed or protracted anaphylactic reactions.
Methylprednisolone and Prednisone: Corticosteroids like methylprednisolone and prednisone have anti-inflammatory properties and can suppress the immune response.
They work by reducing inflammation and preventing the release of inflammatory mediators.
The primary intervention for fatal anaphylaxis is immediate medical treatment, rather than a specific procedure.
Fatal anaphylaxis is a medical emergency, and timely intervention is crucial to prevent a life-threatening outcome.
use-of-phases-in-managing-fatal-anaphylaxis
Prevention phase: The first phase of management begins with allergen avoidance to prevent allergic reactions. Individuals at risk of anaphylaxis should be educated about their allergens and how to avoid them.
Diagnosis phase: Rapidly recognize the signs and symptoms of anaphylaxis, such as difficulty breathing, swelling, hives, low blood pressure, and gastrointestinal symptoms.
Treatment Phase: Administer epinephrine via an epinephrine auto-injector as soon as anaphylaxis is recognized. Epinephrine is the primary and most critical intervention.
Post-Treatment Care: Individuals who have experienced severe anaphylaxis or who do not respond fully to initial treatment may be admitted to the hospital for observation and further care.
Long-Term Management Phase: Continue to emphasize allergen avoidance as a primary preventive measure.
Medication
Future Trends
Media Gallary
References
Anaphylaxis: Emergency Signs, Triggers, and Treatment (verywellhealth.com)
Fatal anaphylaxis, also known as anaphylactic shock or anaphylactic reaction. It is a severe and life-threatening allergic reaction that can occur when an individual is exposed to an allergen to which they are highly sensitive. Anaphylaxis is a medical emergency that requires immediate attention and treatment.
Fatal Anaphylaxis can be triggered by a wide range of allergens. Common allergens include foods (such as peanuts, tree nuts, shellfish, and eggs), insect stings (like bee or wasp stings), medications (especially antibiotics and non-steroidal anti-inflammatory drugs), latex, and certain chemicals.
The symptoms of anaphylaxis can vary but typically include swelling of the face and throat, difficulty in breathing, a drop in blood pressure, rapid and weak pulse, hives or rash, and a sense of impending doom.
When a person with a severe allergy is exposed to their allergen, their immune system reacts excessively to the perceived threat. This immune response involves the release of various chemicals, including histamines, which can lead to a rapid and severe allergic reaction.
Fatal anaphylaxis is relatively rare, but it can occur in individuals of all ages. The exact incidence varies by region and population. Studies have reported an estimated incidence of 0.001% to 0.005% of the general population per year.
Fatal anaphylaxis can affect individuals of any age, but it appears to be more common in adults and older individuals.
The most common triggers of fatal anaphylaxis include food allergens, insect stings and medications (e.g., antibiotics, non-steroidal anti-inflammatory drugs).
Individuals who experience fatal anaphylaxis have a history of known allergies. Having a previous history of severe allergic reactions or a history of anaphylaxis is a significant risk factor.
Fatal anaphylaxis begins when an individual with a heightened sensitivity to a specific allergen is exposed to that allergen.
Anaphylaxis can lead to severe bronchoconstriction because of mediators on the smooth muscles of the respiratory system. This can result in difficulty breathing and respiratory distress.
In individuals with a history of allergy, their immune system has previously been sensitized to the allergen. Upon re-exposure, the allergen interacts with specific IgE antibodies bound to mast cells and basophils, triggering an immediate hypersensitivity reaction.
The interaction between the allergen and IgE antibodies on mast cells and basophils leads to degranulation, causing the release of various inflammatory mediators.
In cases of food allergies, cross-contamination of allergenic substances can lead to inadvertent exposure. This can occur in restaurants, food processing facilities, or homes.
Insect stings, especially from bees and wasps, are a common cause of anaphylaxis. Fatal anaphylaxis occurs when an individual with a heightened sensitivity to a specific allergen is exposed to that allergen,
A significant risk factor for fatal anaphylaxis is a history of known allergies and prior allergic reactions. Individuals who have previously experienced severe allergic reactions, including anaphylaxis, are at higher risk of experiencing a fatal reaction upon subsequent exposure to the allergen.
The most critical prognostic factor in fatal anaphylaxis is the time it takes to initiate appropriate treatment, particularly the administration of epinephrine. Early administration of epinephrine is associated with better outcomes, while delays in treatment can increase the risk of a fatal outcome.
The severity of the allergic reaction plays a significant role in prognosis. More severe reactions, characterized by widespread symptoms such as difficulty breathing, low blood pressure, and altered consciousness, are associated with a higher risk of a fatal outcome.
Age can be a prognostic factor, with pediatric patients often having better outcomes than adults in cases of fatal anaphylaxis. However, severe reactions can occur at any age.
The presence of underlying health conditions, such as cardiovascular disease or respiratory disorders like asthma, can influence the prognosis of fatal anaphylaxis.
Fatal anaphylaxis can occur in infants and children, but it is relatively rare in this age group. Food allergies are often a significant trigger for anaphylactic reactions in children.
Adolescents and young adults can also experience fatal anaphylaxis, especially if they have known allergies and are exposed to their allergens.
Fatal anaphylaxis can occur in adults of all ages. Adults may have a higher prevalence of medication-related anaphylactic reactions, particularly reactions to antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs).
Respiratory Assessment: Observe the patient’s breathing rate and effort. Listen for wheezing, stridor (high-pitched breathing sounds), or other abnormal breath sounds.
Cardiovascular Assessment: Measure the patient’s heart rate (pulse) and blood pressure. In fatal anaphylaxis, there is typically tachycardia (rapid heart rate) and hypotension (low blood pressure).
Skin Assessment: Look for hives or a widespread rash, which is a common sign of anaphylaxis.
Neurological Assessment: Evaluate the patient’s level of consciousness, alertness, and orientation. In severe cases, anaphylaxis can lead to altered mental status or loss of consciousness.
Gastrointestinal Assessment: Examine for nausea, vomiting, abdominal pain, or diarrhea, which may be present in some cases of anaphylaxis.
Oral and Oropharyngeal Examination: Examine the oral cavity and oropharynx for any signs of swelling, including the uvula, tonsils, and posterior pharynx.
Individuals with asthma are at increased risk of severe anaphylaxis. Asthma and anaphylaxis share common features, such as airway inflammation and bronchoconstriction.
When anaphylaxis occurs in individuals with poorly controlled or severe asthma, it can lead to more pronounced respiratory symptoms and a higher risk of respiratory Individuals with cardiovascular conditions, such as coronary artery disease or congestive heart failure, may be at greater risk during anaphylaxis due to the potential for severe drops in blood pressure (hypotension).
Certain autoimmune disorders, such as lupus or rheumatoid arthritis, may affect the immune system and could potentially alter the severity or presentation of anaphylactic reactions.
Individuals with primary immunodeficiency disorders may have impaired immune responses, which can affect their ability to mount a typical allergic response.
Fatal anaphylaxis often has a rapid onset. In many cases, symptoms can develop within minutes of allergen exposure, and the reaction can progress swiftly.
As the allergic reaction worsens, individuals may experience severe respiratory distress. This can include wheezing, stridor (high-pitched breathing sounds), and a sense of suffocation. The airways may become severely narrowed due to bronchoconstriction and swelling.
Stroke: Stroke can sometimes cause neurological symptoms that overlap with those seen in severe allergic reactions, such as altered mental status, confusion, or weakness on one side of the body. Brain imaging (e.g., CT or MRI) can help diagnose a stroke.
Pulmonary Embolism: A pulmonary embolism, a blood clot in the lung arteries, can lead to sudden shortness of breath and chest pain, which may be mistaken for anaphylaxis.
Seizures: Seizures can present with confusion, altered consciousness, and muscle twitching or rigidity, which might be confused with symptoms of anaphylaxis.
Vasovagal Syncope: Vasovagal syncope due to a sudden drop in blood pressure and heart rate, can resemble anaphylaxis with symptoms like dizziness, nausea, and loss of consciousness.
Identification of Anaphylaxis: The first step in the treatment paradigm is recognizing the signs and symptoms of anaphylaxis, which can include difficulty breathing, swelling of the face and throat, a drop in blood pressure, hives, nausea, and a sense of impending doom.
Contact Emergency Assistance: As soon as anaphylaxis is suspected, call the local emergency number for immediate medical assistance. Time is of the essence in anaphylaxis management.
Administration of Epinephrine: Epinephrine is the first-line treatment for anaphylaxis and is administered via an epinephrine auto-injector (e.g., EpiPen) into the outer thigh muscle.
Start with Cardiopulmonary Resuscitation (CPR): If the individual loses consciousness and their pulse stops (cardiac arrest).
Dermatology, General
Emergency Medicine
Avoid Allergen: Identify and confirm specific allergens that trigger anaphylactic reactions in individuals with allergies.
Food Allergy Management: In homes and kitchens, establish safe and unsafe food areas to prevent cross-contact. Ensure that food preparation surfaces and utensils are thoroughly cleaned after use.
Medication Allergies: Inform healthcare providers and pharmacists about known medication allergies to prevent the administration of allergenic medications.
Wear a medical alert bracelet or necklace that specifies medication allergies.
Insect Sting Allergies: For individuals with insect sting allergies, take precautions when outdoors, especially during warm seasons. Wear protective clothing and consider carrying insect repellent.
Emergency Medicine
These agents help maintain blood pressure, antagonize effects of released mediators, and prevent further release of mediators.
Epinephrine: Epinephrine is the first line and most critical medication for anaphylaxis. It acts rapidly to counteract many of the effects of the allergic reaction.
Epinephrine works by constricting blood vessels, which helps raise blood pressure, and by relaxing the muscles in the airways, which improves breathing.
Epinephrine is typically administered via an epinephrine auto-injector into the outer thigh muscle.
Emergency Medicine
Antihistamines, such as diphenhydramine, can be administered to help relieve symptoms like hives, itching, and runny nose.
Antihistamines block the effects of histamine, a chemical released during an allergic reaction.
Diphenhydramine: Diphenhydramine is an H1-receptor antagonist, which means it blocks the effects of histamine, a chemical released during an allergic reaction. By doing so, it can help alleviate symptoms associated with histamine release, such as itching, hives, and runny nose.
Diphenhydramine is typically administered as an adjunctive therapy in the treatment of anaphylaxis. It can help provide relief from itching and skin reactions caused by histamine release.
Hydroxyzine: Hydroxyzine is an H1-receptor antagonist with similar actions in blocking histamine effects. It also has anxiolytic (anxiety-reducing) properties.
Hydroxyzine may be used similarly to diphenhydramine as an adjunctive therapy in the treatment of anaphylaxis. It can help alleviate symptoms like itching and skin reactions.
Emergency Medicine
Bronchodilators like albuterol may be used to relieve bronchoconstriction and improve breathing in individuals with significant respiratory symptoms. They relax the smooth muscles in the airways, making it easier to breathe.
Albuterol: It is a beta-2 adrenergic agonist that works by relaxing the smooth muscles in the airways. It helps open the air passages and improve breathing by relieving bronchoconstriction.
Albuterol may be used as an adjunctive therapy in the treatment of anaphylaxis when there are significant respiratory symptoms, such as wheezing and shortness of breath.
Emergency Medicine
Corticosteroids have anti-inflammatory properties that can help prevent delayed or protracted anaphylactic reactions.
Methylprednisolone and Prednisone: Corticosteroids like methylprednisolone and prednisone have anti-inflammatory properties and can suppress the immune response.
They work by reducing inflammation and preventing the release of inflammatory mediators.
Dermatology, General
Emergency Medicine
The primary intervention for fatal anaphylaxis is immediate medical treatment, rather than a specific procedure.
Fatal anaphylaxis is a medical emergency, and timely intervention is crucial to prevent a life-threatening outcome.
Dermatology, General
Emergency Medicine
Prevention phase: The first phase of management begins with allergen avoidance to prevent allergic reactions. Individuals at risk of anaphylaxis should be educated about their allergens and how to avoid them.
Diagnosis phase: Rapidly recognize the signs and symptoms of anaphylaxis, such as difficulty breathing, swelling, hives, low blood pressure, and gastrointestinal symptoms.
Treatment Phase: Administer epinephrine via an epinephrine auto-injector as soon as anaphylaxis is recognized. Epinephrine is the primary and most critical intervention.
Post-Treatment Care: Individuals who have experienced severe anaphylaxis or who do not respond fully to initial treatment may be admitted to the hospital for observation and further care.
Long-Term Management Phase: Continue to emphasize allergen avoidance as a primary preventive measure.
Anaphylaxis: Emergency Signs, Triggers, and Treatment (verywellhealth.com)
Fatal anaphylaxis, also known as anaphylactic shock or anaphylactic reaction. It is a severe and life-threatening allergic reaction that can occur when an individual is exposed to an allergen to which they are highly sensitive. Anaphylaxis is a medical emergency that requires immediate attention and treatment.
Fatal Anaphylaxis can be triggered by a wide range of allergens. Common allergens include foods (such as peanuts, tree nuts, shellfish, and eggs), insect stings (like bee or wasp stings), medications (especially antibiotics and non-steroidal anti-inflammatory drugs), latex, and certain chemicals.
The symptoms of anaphylaxis can vary but typically include swelling of the face and throat, difficulty in breathing, a drop in blood pressure, rapid and weak pulse, hives or rash, and a sense of impending doom.
When a person with a severe allergy is exposed to their allergen, their immune system reacts excessively to the perceived threat. This immune response involves the release of various chemicals, including histamines, which can lead to a rapid and severe allergic reaction.
Fatal anaphylaxis is relatively rare, but it can occur in individuals of all ages. The exact incidence varies by region and population. Studies have reported an estimated incidence of 0.001% to 0.005% of the general population per year.
Fatal anaphylaxis can affect individuals of any age, but it appears to be more common in adults and older individuals.
The most common triggers of fatal anaphylaxis include food allergens, insect stings and medications (e.g., antibiotics, non-steroidal anti-inflammatory drugs).
Individuals who experience fatal anaphylaxis have a history of known allergies. Having a previous history of severe allergic reactions or a history of anaphylaxis is a significant risk factor.
Fatal anaphylaxis begins when an individual with a heightened sensitivity to a specific allergen is exposed to that allergen.
Anaphylaxis can lead to severe bronchoconstriction because of mediators on the smooth muscles of the respiratory system. This can result in difficulty breathing and respiratory distress.
In individuals with a history of allergy, their immune system has previously been sensitized to the allergen. Upon re-exposure, the allergen interacts with specific IgE antibodies bound to mast cells and basophils, triggering an immediate hypersensitivity reaction.
The interaction between the allergen and IgE antibodies on mast cells and basophils leads to degranulation, causing the release of various inflammatory mediators.
In cases of food allergies, cross-contamination of allergenic substances can lead to inadvertent exposure. This can occur in restaurants, food processing facilities, or homes.
Insect stings, especially from bees and wasps, are a common cause of anaphylaxis. Fatal anaphylaxis occurs when an individual with a heightened sensitivity to a specific allergen is exposed to that allergen,
A significant risk factor for fatal anaphylaxis is a history of known allergies and prior allergic reactions. Individuals who have previously experienced severe allergic reactions, including anaphylaxis, are at higher risk of experiencing a fatal reaction upon subsequent exposure to the allergen.
The most critical prognostic factor in fatal anaphylaxis is the time it takes to initiate appropriate treatment, particularly the administration of epinephrine. Early administration of epinephrine is associated with better outcomes, while delays in treatment can increase the risk of a fatal outcome.
The severity of the allergic reaction plays a significant role in prognosis. More severe reactions, characterized by widespread symptoms such as difficulty breathing, low blood pressure, and altered consciousness, are associated with a higher risk of a fatal outcome.
Age can be a prognostic factor, with pediatric patients often having better outcomes than adults in cases of fatal anaphylaxis. However, severe reactions can occur at any age.
The presence of underlying health conditions, such as cardiovascular disease or respiratory disorders like asthma, can influence the prognosis of fatal anaphylaxis.
Fatal anaphylaxis can occur in infants and children, but it is relatively rare in this age group. Food allergies are often a significant trigger for anaphylactic reactions in children.
Adolescents and young adults can also experience fatal anaphylaxis, especially if they have known allergies and are exposed to their allergens.
Fatal anaphylaxis can occur in adults of all ages. Adults may have a higher prevalence of medication-related anaphylactic reactions, particularly reactions to antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs).
Respiratory Assessment: Observe the patient’s breathing rate and effort. Listen for wheezing, stridor (high-pitched breathing sounds), or other abnormal breath sounds.
Cardiovascular Assessment: Measure the patient’s heart rate (pulse) and blood pressure. In fatal anaphylaxis, there is typically tachycardia (rapid heart rate) and hypotension (low blood pressure).
Skin Assessment: Look for hives or a widespread rash, which is a common sign of anaphylaxis.
Neurological Assessment: Evaluate the patient’s level of consciousness, alertness, and orientation. In severe cases, anaphylaxis can lead to altered mental status or loss of consciousness.
Gastrointestinal Assessment: Examine for nausea, vomiting, abdominal pain, or diarrhea, which may be present in some cases of anaphylaxis.
Oral and Oropharyngeal Examination: Examine the oral cavity and oropharynx for any signs of swelling, including the uvula, tonsils, and posterior pharynx.
Individuals with asthma are at increased risk of severe anaphylaxis. Asthma and anaphylaxis share common features, such as airway inflammation and bronchoconstriction.
When anaphylaxis occurs in individuals with poorly controlled or severe asthma, it can lead to more pronounced respiratory symptoms and a higher risk of respiratory Individuals with cardiovascular conditions, such as coronary artery disease or congestive heart failure, may be at greater risk during anaphylaxis due to the potential for severe drops in blood pressure (hypotension).
Certain autoimmune disorders, such as lupus or rheumatoid arthritis, may affect the immune system and could potentially alter the severity or presentation of anaphylactic reactions.
Individuals with primary immunodeficiency disorders may have impaired immune responses, which can affect their ability to mount a typical allergic response.
Fatal anaphylaxis often has a rapid onset. In many cases, symptoms can develop within minutes of allergen exposure, and the reaction can progress swiftly.
As the allergic reaction worsens, individuals may experience severe respiratory distress. This can include wheezing, stridor (high-pitched breathing sounds), and a sense of suffocation. The airways may become severely narrowed due to bronchoconstriction and swelling.
Stroke: Stroke can sometimes cause neurological symptoms that overlap with those seen in severe allergic reactions, such as altered mental status, confusion, or weakness on one side of the body. Brain imaging (e.g., CT or MRI) can help diagnose a stroke.
Pulmonary Embolism: A pulmonary embolism, a blood clot in the lung arteries, can lead to sudden shortness of breath and chest pain, which may be mistaken for anaphylaxis.
Seizures: Seizures can present with confusion, altered consciousness, and muscle twitching or rigidity, which might be confused with symptoms of anaphylaxis.
Vasovagal Syncope: Vasovagal syncope due to a sudden drop in blood pressure and heart rate, can resemble anaphylaxis with symptoms like dizziness, nausea, and loss of consciousness.
Identification of Anaphylaxis: The first step in the treatment paradigm is recognizing the signs and symptoms of anaphylaxis, which can include difficulty breathing, swelling of the face and throat, a drop in blood pressure, hives, nausea, and a sense of impending doom.
Contact Emergency Assistance: As soon as anaphylaxis is suspected, call the local emergency number for immediate medical assistance. Time is of the essence in anaphylaxis management.
Administration of Epinephrine: Epinephrine is the first-line treatment for anaphylaxis and is administered via an epinephrine auto-injector (e.g., EpiPen) into the outer thigh muscle.
Start with Cardiopulmonary Resuscitation (CPR): If the individual loses consciousness and their pulse stops (cardiac arrest).
Dermatology, General
Emergency Medicine
Avoid Allergen: Identify and confirm specific allergens that trigger anaphylactic reactions in individuals with allergies.
Food Allergy Management: In homes and kitchens, establish safe and unsafe food areas to prevent cross-contact. Ensure that food preparation surfaces and utensils are thoroughly cleaned after use.
Medication Allergies: Inform healthcare providers and pharmacists about known medication allergies to prevent the administration of allergenic medications.
Wear a medical alert bracelet or necklace that specifies medication allergies.
Insect Sting Allergies: For individuals with insect sting allergies, take precautions when outdoors, especially during warm seasons. Wear protective clothing and consider carrying insect repellent.
Emergency Medicine
These agents help maintain blood pressure, antagonize effects of released mediators, and prevent further release of mediators.
Epinephrine: Epinephrine is the first line and most critical medication for anaphylaxis. It acts rapidly to counteract many of the effects of the allergic reaction.
Epinephrine works by constricting blood vessels, which helps raise blood pressure, and by relaxing the muscles in the airways, which improves breathing.
Epinephrine is typically administered via an epinephrine auto-injector into the outer thigh muscle.
Emergency Medicine
Antihistamines, such as diphenhydramine, can be administered to help relieve symptoms like hives, itching, and runny nose.
Antihistamines block the effects of histamine, a chemical released during an allergic reaction.
Diphenhydramine: Diphenhydramine is an H1-receptor antagonist, which means it blocks the effects of histamine, a chemical released during an allergic reaction. By doing so, it can help alleviate symptoms associated with histamine release, such as itching, hives, and runny nose.
Diphenhydramine is typically administered as an adjunctive therapy in the treatment of anaphylaxis. It can help provide relief from itching and skin reactions caused by histamine release.
Hydroxyzine: Hydroxyzine is an H1-receptor antagonist with similar actions in blocking histamine effects. It also has anxiolytic (anxiety-reducing) properties.
Hydroxyzine may be used similarly to diphenhydramine as an adjunctive therapy in the treatment of anaphylaxis. It can help alleviate symptoms like itching and skin reactions.
Emergency Medicine
Bronchodilators like albuterol may be used to relieve bronchoconstriction and improve breathing in individuals with significant respiratory symptoms. They relax the smooth muscles in the airways, making it easier to breathe.
Albuterol: It is a beta-2 adrenergic agonist that works by relaxing the smooth muscles in the airways. It helps open the air passages and improve breathing by relieving bronchoconstriction.
Albuterol may be used as an adjunctive therapy in the treatment of anaphylaxis when there are significant respiratory symptoms, such as wheezing and shortness of breath.
Emergency Medicine
Corticosteroids have anti-inflammatory properties that can help prevent delayed or protracted anaphylactic reactions.
Methylprednisolone and Prednisone: Corticosteroids like methylprednisolone and prednisone have anti-inflammatory properties and can suppress the immune response.
They work by reducing inflammation and preventing the release of inflammatory mediators.
Dermatology, General
Emergency Medicine
The primary intervention for fatal anaphylaxis is immediate medical treatment, rather than a specific procedure.
Fatal anaphylaxis is a medical emergency, and timely intervention is crucial to prevent a life-threatening outcome.
Dermatology, General
Emergency Medicine
Prevention phase: The first phase of management begins with allergen avoidance to prevent allergic reactions. Individuals at risk of anaphylaxis should be educated about their allergens and how to avoid them.
Diagnosis phase: Rapidly recognize the signs and symptoms of anaphylaxis, such as difficulty breathing, swelling, hives, low blood pressure, and gastrointestinal symptoms.
Treatment Phase: Administer epinephrine via an epinephrine auto-injector as soon as anaphylaxis is recognized. Epinephrine is the primary and most critical intervention.
Post-Treatment Care: Individuals who have experienced severe anaphylaxis or who do not respond fully to initial treatment may be admitted to the hospital for observation and further care.
Long-Term Management Phase: Continue to emphasize allergen avoidance as a primary preventive measure.
Anaphylaxis: Emergency Signs, Triggers, and Treatment (verywellhealth.com)
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
